‘Nanodecoy’ therapy binds and neutralizes SARS-CoV-2 virus

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds to rather than targeting the virus itself, nanodecoy therapy could remain effective against emerging variants of the virus. Source

Cell death discovery could lead to new treatment for COPD

Inhibiting necroptosis, a form of cell death, could yield a new treatment approach for chronic obstructive pulmonary disease (COPD), an inflammatory lung condition also known as emphysema, new research shows. The study revealed elevated levels of necroptosis in patients with COPD. By inhibiting necroptosis activity in the lung tissue of COPD patients the researchers found a significant reduction in chronic airway inflammation and lung damage. Source

Stress during pandemic linked to poor sleep

A study found that stress, anxiety and depression during the first few weeks of the pandemic were associated with less and lower quality sleep. In a survey of more than 900 twins, about half of the respondents reported no change in sleep patterns, but 32.9 percent reported decreased sleep. Another 29.8 percent reported sleeping more. The researchers found that any change in sleep was connected to self-reported mental health issues, though more strongly associated with decreased sleep. Source